Latest APMA Health Policy and Advocacy Wins | News | APMA
Latest APMA Health Policy and Advocacy Wins

February 7, 2022

Trophy with gold confetti stars

APMA works tirelessly to advocate for the podiatric medical profession. Over the past year, APMA has been successful in ensuring podiatrists receive equitable reimbursement, and patients have full access to care provided by podiatrists. Recent successes include:

  • HealthNet Federal Services (HNFS), the TRICARE administrator for the West Region, agreed to APMA’s previous request, and now permits podiatrists to order non-invasive vascular or arterial studies for TRICARE beneficiaries.
  • As a result of the efforts of APMA, DME Workgroup, and podiatric CAC representatives for Palmetto Jurisdictions, Palmetto began reimbursing podiatrists for performing remote physiological monitoring (RPM) services.
  • Anthem has agreed with APMA's recommendation to fix its At-Risk Foot Care and -59 Modifier Coding Policy, and now permits paring of calluses (CPT 11055-11057) and debridement of a toenail (CPT 11720/11721) when performed on the same toe if the pared callus was unrelated to and not contiguous with the debrided nail and the callus paring and nail debridement were distinct, unrelated procedures, even when performed on the same toe. 
  • APMA advocated alongside members of the MD/DO community to prevent an almost 10-percent cut in Medicare reimbursement for physicians.

Learn more about recent advocacy successes at www.apma.org/victories.

APMA continues to advocate for members. Learn more about APMA’s current health policy advocacy efforts related to Medicare Advantage chart reviews, -59 Modifier and At-Risk foot care claims, and provider nondiscrimination, among others.


Leave Your Thoughts

Please sign in to leave a comment



Related Resources

APMA Working to Address Aetna At-Risk Foot Care with 59 Modifier Denials

Learn More

Major Victory for First Coast Providers

Learn More

ADVERTISEMENT
Be an advocate for your profession in five minutes or less. Log on today.